Abstracts Archive - Page 335 of 1683 - ATC Abstracts

2020 American Transplant Congress
Pre-Liver Transplant Coronary Artery Disease Work-Up for Non-High-Risk Patients
C. Walker¹, M. Hook², T. Matyja², J. Buggs³, E. Rogers³, A. Kumar¹, N. Kemmer⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²University of Tampa, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: Coronary artery disease is a leading cause of mortality following orthotopic liver transplant, yet there is not currently a standardized protocol for pre-liver-transplant coronary…
2020 American Transplant Congress
Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant
J. Banbury¹, T. Loosier¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…
2020 American Transplant Congress
Predictive Role of the Vitamin B12 in Acute Kidney Injury after Living Donor Liver Transplantation: A Retrospective Observational Cohort Study
J. Park, M. Chae
St.Mary's Hospital, Seoul, Seoul, Korea, Republic of
*Purpose: The aim of our study is to examine the association between serum vitamin B12 level and development of postoperative acute kidney injury (AKI) in…
2020 American Transplant Congress
Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients
Y. Kang, V. M. Aquino, A. Y. Koh, D. Wetzel, P. K. Sue
Pediatrics, UT Southwestern Medical Center, Dallas, TX
*Purpose: Mycobacterium abscessus complex infections are associated with high rates of morbidity and mortality in immunocompromised hosts. Treatment can be challenging due to broad spectrum…
2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
B. M. Chatani¹, J. Garcia², T. Beduschi³, A. Tekin³, R. Vianna³, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, ³Miami Transplant Institute, Miami, FL
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…
2020 American Transplant Congress
Practice Patterns and Provider Adherence to Long Term Management Guidelines in the Post Liver Transplant (LT) Patient
F. Pradhan¹, P. Kang², A. Seetharam¹, S. Mehta¹, R. Nathan¹, M. Fallon¹, N. Patel¹
¹Department of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, AZ, ²Department of Epidemiology and Biostatistics, University of Arizona, Phoenix, AZ
*Purpose: Long-term use of immunosuppression is associated with increased risks of cardiovascular disease, chronic kidney disease, and cancer. We assessed practice patterns and provider adherence…
2020 American Transplant Congress
Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart², D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…
2020 American Transplant Congress
The Relationship Between Frailty and Performance Status in Patients with Cirrhosis Awaiting Liver Transplantation
C. Q. Xu¹, F. Yao², Y. Mohamad², R. Wong², D. Kent², S. Seetharaman², Y. Srisengfa², J. C. Lai²
¹Department of Medicine, UCSF, San Francisco, CA, ²Division of Gastroenterology and Hepatology, Department of Medicine, UCSF, San Francisco, CA
*Purpose: Frailty—a multi-dimensional construct that encapsulates physical function, performance status, and nutritional status—has emerged as a critical determinant of mortality in patients with cirrhosis. Currently,…
2020 American Transplant Congress
National Experience with Living Donor Liver Transplant for Hepatocellular Carcinoma
J. Silverstein¹, F. Yao¹, J. D. Grab², H. Braun², J. Roberts², J. Dodge², N. Mehta¹
¹Dept of Medicine, UCSF, San Francisco, CA, ²Dept of Surgery, UCSF, San Francisco, CA
*Purpose: LDLT is an attractive option to decrease both wait time and risk of waitlist dropout in HCC. This study aimed to evaluate temporal and…
2020 American Transplant Congress
Use of Cell Saver Leads to Lower Consumption of Blood Products During Liver Transplantation
R. Danc
Anesthesiology, Ikem, Prague, Czech Republic
*Purpose: Liver transplantation is often accompanied by significant blood loss and consequently a large consumption of blood products. In recent years, there has been a…